Overall, we observed a decreasing trend in genetic differences, the higher the level of confounder adjustment (see Fig. 2 for Empareg and Supplementary Figs. 1 – 3 for the other RCTs ) .
← all excerpts
Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design.
1
—
—